Literature DB >> 2331838

Late presenting, prolonged hypocalcemia in an infant of a woman with hypocalciuric hypercalcemia.

B R Powell1, N R Buist.   

Abstract

Familial hypocalciuric hypercalcemia (FHH) is a benign autosomal dominant disorder. Infants affected with FHH however, born to unaffected mothers may develop life-threatening autonomous hyperparathyroidism, the mechanism of which is not clearly understood. There is little information recorded in the literature regarding the opposite scenario, i.e., unaffected infants born to affected mothers. Because fetal parathyroid suppression presumably occurs secondary to high maternal calciums, neonatal hypocalcemia would be expected. The authors present a case of an infant with the latter circumstances who presents with late onset, life-threatening hypocalcemia secondary to relative hypoparathyroidism. The authors explored the possibility that vitamin D deficiency and/or acute environmental stress facilitated the decompensation. The patient required therapy for 2 months.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2331838     DOI: 10.1177/000992289002900409

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  4 in total

Review 1.  Calcium and bone metabolism during pregnancy and lactation.

Authors:  Christopher S Kovacs
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-04       Impact factor: 2.673

Review 2.  Familial benign hypercalcemia--from clinical description to molecular genetics.

Authors:  H Heath
Journal:  West J Med       Date:  1994-06

Review 3.  Parathyroid Disease in Pregnancy and Lactation: A Narrative Review of the Literature.

Authors:  Elena Tsourdi; Athanasios D Anastasilakis
Journal:  Biomedicines       Date:  2021-04-26

4.  Neonatal Hypocalcemic Seizures in Offspring of a Mother With Familial Hypocalciuric Hypercalcemia Type 1 (FHH1).

Authors:  Poonam Dharmaraj; Caroline M Gorvin; Astha Soni; Nick D Nelhans; Mie K Olesen; Hannah Boon; Treena Cranston; Rajesh V Thakker; Fadil M Hannan
Journal:  J Clin Endocrinol Metab       Date:  2020-05-01       Impact factor: 5.958

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.